Certified by Founder Lodge
Hikma Ventures
United Kingdom - London, England
INVESTOR
1 Disclosed Funding Rounds $23,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Our primary focus is to identify and invest in emerging companies in the digi
| Company | Date | Round | Raised |
|---|---|---|---|
 Prognos Health |
May, 18 ,2023 | Unknown | $23,000,000 |
 Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
